Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Daly

Showing results (381-390 of 397) with videos related to

Pageof 40
Sort By:
Diagnostic and Prognostic Research|September 12, 2023
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control studyJane I Grove, Camilla Stephens, M Isabel Lucena, et al.
Gastroenterology|May 17, 2011
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II allelesM Isabel Lucena, Mariam Molokhia, Yufeng Shen, et al.
Ebiomedicine|March 25, 2026
Usefulness of plasma bile acid profile as a prognostic biomarker for drug-induced liver injuryMaria J Monte, Thi Dong-Binh Tran, Jane I Grove, et al.
Journal of Hepatology|October 17, 2021
A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkersJohn B Whitfield, Tae-Hwi Schwantes-An, Rebecca Darlay, et al.
Journal of Hepatology|December 23, 2021
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver diseaseOlivier Govaere, Sine Kragh Petersen, Nuria Martinez-Lopez, et al.
Hepatology Communications|May 10, 2024
A polygenic risk score for alcohol-associated cirrhosis among heavy drinkers with European ancestryTae-Hwi Schwantes-An, John B Whitfield, Guruprasad P Aithal, et al.
Nature Genetics|May 18, 2026
Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitisMarkus Boesch, Seray Anak, Dania El Abyad, et al.
Gastroenterology|January 4, 2017
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association StudyPaola Nicoletti, Guruprasad P Aithal, Einar S Bjornsson, et al.
Clinical Pharmacology and Therapeutics|October 20, 2015
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reportingL V Kalman, Jag Agúndez, M Lindqvist Appell, et al.
Nature Metabolism|June 12, 2024
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, et al.
Pageof 40

Showing results (381-390 of 397) with videos related to

Sort By:
Pageof 40
Diagnostic and Prognostic Research|September 12, 2023
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control studyJane I Grove, Camilla Stephens, M Isabel Lucena, et al.
Gastroenterology|May 17, 2011
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II allelesM Isabel Lucena, Mariam Molokhia, Yufeng Shen, et al.
Ebiomedicine|March 25, 2026
Usefulness of plasma bile acid profile as a prognostic biomarker for drug-induced liver injuryMaria J Monte, Thi Dong-Binh Tran, Jane I Grove, et al.
Journal of Hepatology|October 17, 2021
A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkersJohn B Whitfield, Tae-Hwi Schwantes-An, Rebecca Darlay, et al.
Journal of Hepatology|December 23, 2021
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver diseaseOlivier Govaere, Sine Kragh Petersen, Nuria Martinez-Lopez, et al.
Hepatology Communications|May 10, 2024
A polygenic risk score for alcohol-associated cirrhosis among heavy drinkers with European ancestryTae-Hwi Schwantes-An, John B Whitfield, Guruprasad P Aithal, et al.
Nature Genetics|May 18, 2026
Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitisMarkus Boesch, Seray Anak, Dania El Abyad, et al.
Gastroenterology|January 4, 2017
Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association StudyPaola Nicoletti, Guruprasad P Aithal, Einar S Bjornsson, et al.
Clinical Pharmacology and Therapeutics|October 20, 2015
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reportingL V Kalman, Jag Agúndez, M Lindqvist Appell, et al.
Nature Metabolism|June 12, 2024
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)Michele Vacca, Ioannis Kamzolas, Lea Mørch Harder, et al.
Pageof 40